Artículos por temáticas

The influence and the mechanism of docosahexaenoic acid on a mouse model of Parkinson's disease.

Ozsoy O, Seval-Celik Y, Hacioglu G, Yargicoglu P, Demir R, Agar A, Aslan M.

Neurochem Int. 2011 Oct;59(5):664-70. doi: 10.1016/j.neuint.2011.06.012.

A cost analysis of intraoperative microelectrode recording during subthalamic stimulation for Parkinson's disease.

McClelland S 3rd.

Mov Disord. 2011 Jul;26(8):1422-7. doi: 10.1002/mds.23787.

Idiopathic Parkinson's syndrome. Preface.

Korczyn AD, Reichmann H, Tolosa E.

J Neurol Sci. 2011 Nov 15;310(1-2):1. doi: 10.1016/j.jns.2011.08.011. No abstract available.

Pathways towards an effective immunotherapy for Parkinson's disease.

Hutter-Saunders JA, Mosley RL, Gendelman HE.

Expert Rev Neurother. 2011 Dec;11(12):1703-15. doi: 10.1586/ern.11.163. Review.

Behavioural disorders, disability and quality of life in Parkinson's disease.

Leroi I, Ahearn DJ, Andrews M, McDonald KR, Byrne EJ, Burns A.

Age Ageing. 2011 Sep;40(5):614-21. doi: 10.1093/ageing/afr078.

The movement disorder society and movement disorders: a modern history.

Goetz CG, McGhiey A.

Mov Disord. 2011 May;26(6):939-46. doi: 10.1002/mds.23689. Review.

Authors' replies to the comments of Giugni et al. on Hiccups in Parkinson's disease: an overlooked non-motor symptom?"."

Miwa H, Kondo T.

Parkinsonism Relat Disord. 2011 Sep;17(8):653. doi: 10.1016/j.parkreldis.2010.08.006. No abstract available.

[Detection and management of non-motor symptoms in Parkinson's disease: impact on their prevalence].

Rodríguez-Violante M, Cervantes-Arriaga A.

Rev Med Chil. 2011 Aug;139(8):1032-8. doi: /S0034-98872011000800008. Spanish.

Rosiglitazone decreases peroxisome proliferator receptor-γ levels in microglia and inhibits TNF-α production: new evidences on neuroprotection in a progressive Parkinson's disease model.

Carta AR, Frau L, Pisanu A, Wardas J, Spiga S, Carboni E.

Neuroscience. 2011 Oct 27;194:250-61. doi: 10.1016/j.neuroscience.2011.07.046.

Amelioration of osteoporosis and hypovitaminosis D by sunlight exposure in Parkinson's disease.

Sato Y, Iwamoto J, Honda Y.

Parkinsonism Relat Disord. 2011 Jan;17(1):22-6. doi: 10.1016/j.parkreldis.2010.10.008.

LRRK2 R1398H polymorphism is associated with decreased risk of Parkinson's disease in a Han Chinese population.

Chen L, Zhang S, Liu Y, Hong H, Wang H, Zheng Y, Zhou H, Chen J, Xian W, He Y, Li J, Liu Z, Pei Z, Zeng J.

Parkinsonism Relat Disord. 2011 May;17(4):291-2. doi: 10.1016/j.parkreldis.2010.11.012. No abstract available.

Longitudinal change in regional brain volumes in prodromal Huntington disease.

Aylward EH, Nopoulos PC, Ross CA, Langbehn DR, Pierson RK, Mills JA, Johnson HJ, Magnotta VA, Juhl AR, Paulsen JS; PREDICT-HD Investigators and Coordinators of Huntington Study Group..

J Neurol Neurosurg Psychiatry. 2011 Apr;82(4):405-10. doi: 10.1136/jnnp.2010.208264.

Nociceptive inputs transmission in Huntington's disease: a study by laser evoked potentials.

De Tommaso M, Serpino C, Difruscolo O, Cormio C, Sciruicchio V, Franco G, Farella I, Livrea P.

Acta Neurol Belg. 2011 Mar;111(1):33-40.

A distinctive pattern of cortical excitability in patients with the syndrome of dystonia and cerebellar ataxia.

Talelli P, Hoffland BS, Schneider SA, Edwards MJ, Bhatia KP, van de Warrenburg BP, Rothwell JC.

Clin Neurophysiol. 2011 Sep;122(9):1816-9. doi: 10.1016/j.clinph.2011.02.029.

Increased prevalence of restless legs syndrome in patients with acromegaly and effects on quality of life assessed by Acro-QoL.

Cannavò S, Condurso R, Ragonese M, Ferraù F, Alibrandi A, Aricò I, Romanello G, Squadrito S, Trimarchi F, Silvestri R.

Pituitary. 2011 Dec;14(4):328-34. doi: 10.1007/s11102-011-0298-z.